Netherlands· NL-c1aa0669944a
Hepcludex 2 mg poeder voor oplossing voor injectie
A bulevirtide product containing bulevirtideacetaat, registered in Netherlands by Gilead Sciences Ireland UC. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Bulevirtide is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AX28 (bulevirtide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Bulevirtide · ATC J05AX28
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bulevirtide costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bulevirtide · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$219.16
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- BULEVIRTIDEACETAAT
- Manufacturer
- Gilead Sciences Ireland UC
- Country
- Netherlands (NL)
- ATC code
- J05AX28
- ATC class
- Bulevirtide
- Defined daily dose
- 2 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/20/1446
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bulevirtide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceHEPCLUDEX 2 mg, poudre pour solution injectableGILEAD SCIENCES IRELAND UC (IRLANDE)
- IrelandHEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ireland UC
- SpainHEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLEGilead Sciences Ireland Unlimited Company
- United KingdomHepcludex 2mg powder for solution for injection vialsGilead Sciences Ltd
- IcelandHepcludexGilead Sciences Ireland UC*
- ItalyHEPCLUDEX*30 flaconcini SC polv 2 mgGILEAD SCIENCES IRELAND UC
- NorwayHepcludexGilead Sciences Ireland UC
- PolandHepcludexGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Hepcludex
- Liechtenstein · Hepcludex
- Norway · Hepcludex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8419d602-4b8b-4218-bec0-1dec4d8d13f2 GET /v1/drugs/8419d602-4b8b-4218-bec0-1dec4d8d13f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/hepcludex-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Bulevirtide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp125758",
"excipients": [
"MANNITOL (D-) (E 421)",
"NATRIUMCARBONAAT 0-WATER (E 500 (I))",
"NATRIUMHYDROXIDE (E 524)",
"NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
"ZOUTZUUR (E 507)"
],
"substances": [
"BULEVIRTIDEACETAAT"
],
"leaflet_url": null,
"authorised_at": "2020/07/31",
"procedure_number": "EMEA/H/C/004854",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/20/1446",
"additional_monitoring": "Y"
}See everything about bulevirtide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.